Yong Ming Li

7582611, Sep 1, 2009

May 2, 2006

11/416519

Yaoquan Liu - Castro Valley CA, US
Christopher Carreras - Belmont CA, US
David C. Myles - Kensington CA, US
Yong Li - Palo Alto CA, US
Simon James Shaw - San Francisco CA, US
Hong Fu - Union City CA, US
Yue Chen - Hayward CA, US
Hao Zheng - Hayward CA, US
Yandong Li - San Jose CA, US
Mark A. Burlingame - Oakland CA, US

Pfizer Inc. - New York NY

A61K 31/70
C07H 17/08

514 29, 536 72, 536 73, 536 74

Compounds having a structure according to formula (I).

7640548, Dec 29, 2009

Jun 21, 2002

10/177534

Jai Yu - Fremont CA, US
Karn Choi - Seattle WA, US
Stephan Otto Brunner - Lafayetta CA, US
Do Joon Ra - Mountain View CA, US
Guo Chew Lam - Foster City CA, US
Aibek Musaev - San Mateo CA, US
Ashley Grant Stirrup - Burlingame CA, US
Tarri E. Furlong - San Leandro CA, US
Yong Li - Fremont CA, US

Siebel Systems, Inc. - San Mateo CA

G06F 9/46
G06F 3/00

718106, 705 8, 705 9, 715708, 715751, 715753

A facility for guiding users through a series of steps or tasks, often associated with a process, is described. The facility assigns tasks or steps to users having roles identified with the task or step. The role associated with the task or step may change depending on the state of the task or step. When the role associated with a task or step changes, the facility may assign the task or step to another user. The facility guides a user through a task or step by providing instructions and other information, such as data tables and user input fields, that may be used to complete the task or step. The facility provides for the definition of processes by allowing users to specify tasks, steps and instructions relating to processes.

7955824, Jun 7, 2011

May 9, 2008

12/118432

John R. Carney - Hayward CA, US
Yong Li - Hayward CA, US
Hugo Menzella - Hayward CA, US
Ralph C. Reid - Hayward CA, US

Kosan Biosciences Incorporated - Princeton NJ

C12P 17/06

435125, 549292, 549417, 558250, 558254

The invention provides novel compounds that may be used as intermediates in the preparation of epothilones, epothilone analogs and derivative, as well as new synthetic methods for producing the intermediates and products.

8030503, Oct 4, 2011

May 9, 2008

12/117876

Yue Chen - Hayward CA, US
Yong Li - Palo Alto CA, US

Kosan Biosciences Incorporated - Princeton NJ

C07D 309/30

549292

Intermediates in the preparation of epothilones and epothilone analogs are provided along with synthetic methods useful in the synthesis of epothilone compounds.

8063021, Nov 22, 2011

Jun 30, 2004

10/883317

Yong Li - Palo Alto CA, US
Yandong Li - San Leandro CA, US
Yan Zhu - Foster City CA, US
Chaitan Khosla - Palo Alto CA, US
David C. Myles - Kensington CA, US

Kosan Biosciences Incorporated - Princeton NJ

A61K 31/70
C07H 17/08

514 29, 536 74

Compounds according to formula I.

8410305, Apr 2, 2013

Nov 12, 2008

12/741757

Yue Chen - Tianjin, CN
Yong Li - Palo Alto CA, US

Kosan Biosciences Incorporated - Hayward CA

C07C 69/66
C07C 233/00

560183, 560179, 564204, 564205

Highly efficient methods are provided for preparing key intermediates in the synthesis of epothilones and use new alane reagents which are broadly applicable and can provide selected components having a variety of substituents groups.

7362812, Apr 22, 2008

May 6, 2004

10/839265

Ping Hou - San Carlos CA, US
Yong Li - Sunnyvale CA, US

Advanced Micro Devices, Inc. - Sunnyvale CA

H04K 1/10

375260, 375149, 375130, 375346, 375354, 375355

A channel tracking module, configured for generating updated equalization coefficients for a frequency equalizer, is configured for determining a digital-based error value between equalized signals output by the frequency equalizer relative to predicted signals, for each subcarrier frequency of an OFDM symbol. The channel tracking module determines an accumulated error based on accumulating the digital-based error values for all the subcarrier frequencies of the OFDM symbol, for a prescribed successive number of OFDM symbols. The channel tracking module also determines a step size based on the accumulated error and relative to a prescribed step function configured for optimizing equalizer adjustments within stability limits. The channel tracking updates the equalization coefficients for each subscarrier frequency based on the accumulated error and the step size. Hence, the channel tracking module can be implemented in an economical manner while ensuring optimum equalizer adjustments within stability limits that ensure convergence of the equalization coefficients.

20020128213, Sep 12, 2002

Sep 24, 2001

09/969177

Leonard Katz - Oakland CA, US
Gary Ashley - Alameda CA, US
Mark Burlingame - San Francisco CA, US
Steven Dong - San Francisco CA, US
Hong Fu - Union City CA, US
Yong Li - Palo Alto CA, US
David Myles - Kensington CA, US

A61K031/7048
C07H017/08

514/030000, 536/007100

The present invention provides novel sixteen-membered macrolide compounds that are useful as anti-infective agents or as intermediates thereto. The present invention also provides methods for the preparation of these compounds, and methods and formulations for their use. In one aspect of the present invention, sixteen-membered macrolide possessing a side chain Z are provided where Z is aliphatic, aryl, alkylaryl, halide, NOR, NNHR, or —W—Rwhere W is O, S, NC( O)R, NC( O)OR, NC( O)NHRor NRwhere Rand Rare each independently hydrogen, aliphatic, aryl or alkylaryl. In another aspect of the present invention, bicyclic compounds are provided where one of the cyclic-components is a sixteen-membered macrolide and the other is a cyclic moiety whose cyclic structure is formed by between 3 and 10 atoms. In another aspect of the present invention, sixteen-membered macrolide compounds that bind to the domain II region of the 23S RNA are provided.